Moreover, the number of GFAP-positive astrocytes surrounding the BBB was significantly less in ML on the cortex region of patients with AD (AD) relative to non-AD donor (Normal) (Figure 1A and Figure S1). This evidence concerns the gene GFAP and Alzheimer disease.